Skip to content
★ Sign in to follow
KS

Kai-Uwe Schässburger

NeoDynamics AB (publ)
Total declarations
16
Company
1
▲ Purchases (13 ops.)
€60k
▼ Sales (2 ops.)
€6,295

Latest filing published 17 Aug 2023 for NeoDynamics ab (publ), €16k.

Filing timeline

BuySale
Kai-Uwe Schässburger

Insider track record

Disclosed buys
13
Disclosed sells
2
Signal history

Closed purchases

Market purchases
13

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kai-Uwe Schässburger: trading record in brief

Kai-Uwe Schässburger appears in our data through filings on NeoDynamics AB (publ) shares, published by Finansinspektionen. In total, 16 filings cover trades dated from 21 December 2018 to 17 August 2023.

Market trades split into 13 purchases (€60k) and 2 sales (€6,295). Taken together, the purchases exceed the sales by €54k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €3,802 and half below. Of 10 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 17 August 2023 with an open-market purchase (€16k) in NeoDynamics AB (publ). The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kai-Uwe Schässburger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    189,494 SEK0FI-SE
    315,823 shares@ SEK 0.6021.5% of flowBTU (betald tecknad unit)ISIN SE0020552735FI:csv-98e17c39bc72b827d64f
    Canonical exit: 15 Nov 2023 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    14,315 SEK14FI-SE
    19,993 shares@ SEK 0.7162.3% of flowAktieISIN SE0011563410FI:csv-ee1d1d504c5d390b97d7
    Canonical exit: 11 Oct 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    44,095 SEK15FI-SE
    61,413 shares@ SEK 0.7187.1% of flowAktieISIN SE0011563410FI:csv-c1a21b726d0b6f47da3e
    Canonical exit: 11 Oct 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    13,536 SEK14FI-SE
    18,594 shares@ SEK 0.7282.2% of flowAktieISIN SE0011563410FI:csv-181f7f8438d2d98ef72a
    Canonical exit: 11 Oct 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    22,562 SEK2FI-SE
    24,823 shares@ SEK 0.90893.6% of flowAktieISIN SE0011563410FI:csv-6badf05834ca286f3c9c
    Canonical exit: 27 Sept 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    875 SEK14FI-SE
    1,000 shares@ SEK 0.8750.1% of flowAktieISIN SE0011563410FI:csv-95c1b6f7754957dd706f
    Canonical exit: 8 Sept 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    40,650 SEK3FI-SE
    50,000 shares@ SEK 0.8136.5% of flowAktieISIN SE0011563410FI:csv-6c87f43d28c85fc823ec
    Canonical exit: 27 Sept 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    31,960 SEK3FI-SE
    40,000 shares@ SEK 0.7995.1% of flowAktieISIN SE0011563410FI:csv-b93a3ae94b06c17c3106
    Canonical exit: 28 Sept 2022 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesNeoDynamics AB (publ)
    45,500 SEK0FI-SE
    350,000 shares@ SEK 0.137.6% of flowTeckningsoptionISIN SE0011563410FI:csv-87cb5a19a800c900efa6
    Canonical exit: 5 Jul 2022 (T+90)
  • ●
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    80,000 SEK0FI-SE
    250,000 shares@ SEK 0.3220.4% of flowTeckningsoptionFI:csv-d47b053da1b246fae6d6
  • ▲
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    46,626 SEK12FI-SE
    17,933 shares@ SEK 2.6011.6% of flowAktieISIN SE0011563410FI:csv-dd495e482ed5b01e43ea
    Canonical exit: 22 Sept 2020 (T+90)
  • ▲
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    5,312 SEK11FI-SE
    2,067 shares@ SEK 2.571.3% of flowAktieISIN SE0011563410FI:csv-488e3922863845c8be9e
    Canonical exit: 22 Sept 2020 (T+90)
  • ▼
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    51,753 SEK13FI-SE
    15,001 shares@ SEK 3.4515.6% of flowAktieISIN SE0011563410FI:csv-967a62d51962c1c8c9ed
  • ▼
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    17,297 SEK12FI-SE
    4,999 shares@ SEK 3.465.2% of flowAktieISIN SE0011563410FI:csv-d0772dbf27e5f5a5ff04
  • ▲
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    44,000 SEK24FI-SE
    10,000 shares@ SEK 4.4010.8% of flowAktieISIN SE0011563410FI:csv-6e33c04049be671b3b90
    Canonical exit: 21 Aug 2019 (T+90)
  • ▲
    Director Clinical Development & Medical AffairsExecutivesNeoDynamics AB (publ)
    153,000 SEK0FI-SE
    180,000 shares@ SEK 0.8539.2% of flowTeckningsoptionFI:csv-6ec50c1726a3c07d5a60
    Canonical exit: 21 Mar 2019 (T+90)

16 of 16 declarations